A passion for snakes opened a crack in the religious beliefs science communicator Paul Martin Jensen grew up with in a ...

The official, Chris Klomp, said last week that the most-favored nation deals aim to increase the prices of new drugs in peer ...

In this excerpt from their new book “Whiplash,” David Blumenthal and James A. Morone describe how scientists became villains ...

Doctronic, the startup behind a provocative experiment in Utah to renew drug prescriptions with a chatbot, has raised $40 ...

A new paper shows that women, particularly those early in their careers, have been disproportionately affected by NIH grant ...

A recent Epic lawsuit revealed a company allegedly posed as a provider to access patient records for law firms, prompting a ...

A STAT investigation explores how a new company is profiting from the arbitration process in the No Surprises Act.

In today's Morning Rounds newsletter: the high-stakes search for a new CDC director, the impact of immigration policy on ...

New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech ...

Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...

A proposal in the Tennessee legislature could force CVS Health to sever a core piece of its business model or exit the state ...

An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...